BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8266105)

  • 21. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.
    Drummond IA; Rupprecht HD; Rohwer-Nutter P; Lopez-Guisa JM; Madden SL; Rauscher FJ; Sukhatme VP
    Mol Cell Biol; 1994 Jun; 14(6):3800-9. PubMed ID: 8196623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
    Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS
    EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S; Royer-Pokora B
    Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis.
    Englert C; Hou X; Maheswaran S; Bennett P; Ngwu C; Re GG; Garvin AJ; Rosner MR; Haber DA
    EMBO J; 1995 Oct; 14(19):4662-75. PubMed ID: 7588596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eel WT1 sequence and expression in spontaneous nephroblastomas in Japanese eel.
    Nakatsuru Y; Minami K; Yoshikawa A; Zhu J; Oda H; Masahito P; Okamoto N; Nakamura Y; Ishikawa T
    Gene; 2000 Mar; 245(2):245-51. PubMed ID: 10717475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent association of beta-catenin and WT1 mutations in Wilms tumors.
    Maiti S; Alam R; Amos CI; Huff V
    Cancer Res; 2000 Nov; 60(22):6288-92. PubMed ID: 11103785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA binding by the Wilms tumor suppressor zinc finger proteins.
    Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA processing. Wilms' tumour--the splicing connection?
    Lamond AI
    Curr Biol; 1995 Aug; 5(8):862-5. PubMed ID: 7583142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
    Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of a novel truncated WT1 transcript in human neoplasia.
    Dechsukhum C; Ware JL; Ferreira-Gonzalez A; Wilkinson DS; Garrett CT
    Mol Diagn; 2000 Jun; 5(2):117-28. PubMed ID: 11066013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
    Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
    J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
    Fraizer GC; Shimamura R; Zhang X; Saunders GF
    J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
    Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ; Wang ZY; Deuel TF; Xu YH
    Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
    Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
    Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing.
    Larsson SH; Charlieu JP; Miyagawa K; Engelkamp D; Rassoulzadegan M; Ross A; Cuzin F; van Heyningen V; Hastie ND
    Cell; 1995 May; 81(3):391-401. PubMed ID: 7736591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.